dc.creatorFerreira, Aline S.
dc.creatorBarbosa, Nádia R.
dc.creatorSilva, Silvio S
dc.date2009-06-22T03:00:00Z
dc.date2009
dc.date.accessioned2017-03-08T20:12:28Z
dc.date.available2017-03-08T20:12:28Z
dc.identifierhttp://hdl.handle.net/10915/7745
dc.identifierhttp://www.latamjpharm.org/trabajos/28/2/LAJOP_28_2_1_4_Y0R1N0PXBL.pdf
dc.identifierhttp://sedici.unlp.edu.ar/handle/10915/7745
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/429812
dc.descriptionXylitol is a widely studied sugar with therapeutic properties and is effective against microorganisms. Despite a variety of toxicological data being available about this compound, dermal toxicological tests cannot be found. Here, the aim was to carry out in vivo assays to verify xylitol skin application safety. Primary dermal irritation studies were done with rabbits using 5 and 10% (w/w) xylitol, in either cream or gel form. Phototoxicity assays were also performed with guinea pigs, using only 10% (w/w) xylitol, in both forms. Primary dermal irritation studies revealed that xylitol topically used (5 and 10%) did not induce erythema or edema formation, but did show phototoxicity properties. Xylitol is an adequate alternative compound to be applied for skin disease control, since this application will be done together with sunscreen.
dc.languageen
dc.relationLatin American Journal of Pharmacy
dc.relationvol. 28, no. 2
dc.subjectpharmaceutical preparations; phototoxicity; primary dermal irritation study; xylitol
dc.subjectFarmacia
dc.subjectMedicamento
dc.subjectComposición de medicamentos
dc.subjectFarmacología
dc.subjectToxicología
dc.subjectEvaluación de Medicamentos
dc.titleIn vivo xylitol primary dermal irritation and phototoxicity evaluation
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución